Public health & disease

Empty office desk and chairs

Germany launches large four-day workweek trial

In February, 45 companies and organizations in Europe’s largest economy will introduce a 4-day workweek for half a year. Employees will continue to receive their full salary. Advocates argue that a 4-day workweek would increase worker productivity and, by consequence, help alleviate the country’s skilled labor shortage.

Chromosomes

Gene therapy hailed as ‘medical magic wand’ for hereditary swelling disorder

Hereditary angioedema, or HAE, is a rare disease that affects about one in 50,000 people. It is caused by a genetic mutation that leaves patients with leaky blood vessels, causing erratic bouts of swelling. Dr. Hilary Longhurst, the principal investigator at New Zealand’s Te Toka Tumai, Auckland City hospital, said the new single-dose therapy appeared to provide a permanent cure for her patients’ “very disabling symptoms”.

Back of a school bus

Miami commits to putting 100 electric school buses on the road

Miami-Dade county is set to receive nearly $20 million from the Environmental Protection Agency to help cover the costs of 50 new electric school buses and 16 DC fast chargers, bringing the public school district’s total to 100 electric buses. Miami-Dade county is one of four school districts selected to receive a total of $33,175,000 through the EPA’s first Clean School Bus Program’s Grants Competition.

Person having blood drawn

Breakthrough Alzheimer’s blood test could detect disease 15 years before symptoms emerge

A recent trial of 786 people – conducted by Dr. Nicholas Ashton at the University of Gothenburg in Sweden and colleagues – found the new test to be as accurate at detecting the signs of Alzheimer’s as painful lumbar punctures, and better than a range of other tests currently being worked on. Experts say it could pave the way for national screening programs for people 50 and over, and that current treatments could work better with the cases picked up earlier.

Mosquito

Historic malaria vaccine rollout begins in Cameroon

The rollout of the world’s first malaria vaccine has begun in Cameroon, which is said to usher in a “transformative chapter in Africa’s public health history”. The RTS,S vaccine – 662,000 doses of it – will be administered to children in the west African country, the first to be vaccinated after successful trials of the drug in Ghana, Kenya, and Malawi between 2019 and 2021.

Doctor holding vial of HPV vaccine

No cervical cancer cases in HPV-vaccinated women in Scotland

A new study from Public Health Scotland has found that no cases of cervical cancer have been detected in young women who have been fully-vaccinated as part of the HPV immunization program, concluding that the vaccine was “highly effective” in preventing the development of the cancer. Scotland’s HPV vaccination program started in 2008 with girls offered the vaccine in their first year at secondary school.

Person receiving shot in the arm

Cancer vaccine with minimal side effects nearing Phase 3 clinical trials

The vaccine- developed by Dr. Thomas Wagner of U.S.-based Orbis Health Solutions – has already been tested in hundreds of patients with advanced forms of melanoma in Phase 2 clinical trials. The most recent data showed nearly 95% of people given only the vaccine were still alive three years after starting treatment and 64% were still disease-free. Among the most advanced forms of melanoma, disease-free survival after three years for people with stage III disease was 60% in the vaccine-only group, compared to about 39% in the placebo group.

Mosquito

Cape Verde is declared malaria-free

Cape Verde, an island nation off the coast of West Africa, was given the status by the World Health Organization (WHO) as it has not reported a single case of local transmission in three years. Experts have hailed this as a major achievement. It’s the first time a sub-Saharan African nation has been declared malaria-free in 50 years.

Person happily holding a trans pride flag

Maryland to cover unprecedented number of gender-affirming procedures in “groundbreaking” win

A new law in Maryland requires Medicaid to cover “medically necessary” gender-affirming care for residents — including care well beyond hormones or surgery. The law went into effect on January 1. It requires coverage for “gender-affirming treatment in a nondiscriminatory manner.” Gender-affirming care is considered safe and essential to the well-being of trans people by the American Academy of Pediatrics, the American Medical Association, the American Psychological Association, and other major U.S. and world health organizations.

Scroll to Top